Bristol-Myers Squibb Co at Wolfe Research Healthcare Conference (Virtual) Transcript
Okay. Well, good morning and thank you to everyone for joining us to our Wolfe health care conference that runs today and tomorrow. We have a host of companies from my coverage, from Justin Lake's coverage, from Andrew Galler's coverage. And most of these sessions will be fireside chats. And we're going to kick things off this morning with Giovanni Caforio. He's the Chairman and CEO of Bristol-Myers Squibb. He has been with the company for quite some time, I think since 2000. And in case you missed it yesterday, the company held a very comprehensive Analyst Day, running through many aspects of the business, pipeline, key marketed products, future patent expiries, what Bristol is trying to do to stay [relevant]. And there was a lot of content. So why don't we start with some general questions, Giovanni?
Questions & Answers
So 2021 is coming to an end, just 6 weeks left. How is the setup for 2022 looking for Bristol?
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
